Patents by Inventor John Edwin MacNintch

John Edwin MacNintch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mixture of calcium carbonate and calcium-.alpha.-p-chlorophenoxyisobutyrate as an antihyperlipemic agent
    Patent number: 3952096
    Abstract: Calcium .alpha.-p-chlorophenoxyisobutyrate, particularly as its novel monohydrate, when combined with about one to two parts by weight of calcium carbonate in oral dosage form for use in mammals, and especially man, provides a safe and effective composition for reducing elevated blood levels of cholesterol, triglycerides and/or low density lipoproteins and/or increasing fibrinolytic activity and/or decreasing platelet aggregation. A preferred embodiment is a capsule containing 500 mgm. calcium carbonate and 250 or 500 mgm. crystalline calcium .alpha.-p-chlorophenoxyisobutyrate monohydrate having the empirical formula C.sub.10 H.sub.10 ClO.sub.3 Ca.sub.1/2.H.sub.2 O.
    Type: Grant
    Filed: June 15, 1973
    Date of Patent: April 20, 1976
    Assignee: Bristol-Myers Company
    Inventors: John Carl Godfrey, John Edwin MacNintch, Joseph Rubinfeld